Its mechanism of improving pulmonary fibrosis was closely related to inhibition of TGF-β1 production and inhibition of monocytes differentiation into pro-inflammatory macrophages and prefibrous fibroblasts [73–75]. The gene discussed is TGFB1; the disease is pulmonary fibrosis.